TrialJournal for immunotherapy of cancer2024

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses.

Nathan D Seligson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.